Nov. 14, 2017 Price forecast | 2 weeks: 3.74% | 1 month: 5.29% | 3 months: 11.20% | Premium Forecast


PRTO stock forecast

Our latest prediction for Proteon Therapeutics, Inc.'s stock price was made on the Nov. 14, 2017 when the stock price was at 1.70$.

In the short term (2weeks), PRTO's stock price should outperform the market by 3.74%. During that period the price should oscillate between -10.17% and +19.60%.

In the medium term (3months), PRTO's stock price should outperform the market by 11.20%. During that period the price should oscillate between -20.53% and +55.64%.

Create a solid portfolio with PRTO

Add PRTO to your portfolio and optimize it!


About Proteon Therapeutics, Inc.

Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -1.18$ per share.

The book value per share is 0.23$

Proteon Therapeutics, Inc. website


Three months stock forecastNov. 14, 2017


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -22M - -21M -1.18 - - 18M 0.23 -25M - -25M